RE:Anyone following the strategy in the background ?Another great post MrMugsy!
Profound's strategy of more aggressive expansion of recurring non-capital revenue in the US is bound to benefit from partner Akumin's own aggressive expansion. It can only be a positive for Profound, maybe a huge positive.
Might the potential Akumin sees in treatment of prostate conditions with TULSA-PRO have provided some impetus to expand?
Do you know how big Akumin was before in terms of states, hospitals and clinics?
MrMugsy wrote: So Profound has partnered with RadNet and Akumin Inc on the imaging centers side of things.
Akumin recently made a blockbuster acquisition (Alliance Healthcare Services).
As I understand it ... Akumin is now in 46 states, partnered with over 1,000 hospitals and has 188 imaging and radiation therapy clinics (as of September 2021).
One small problem ... Akumin is having some financial accounting issues of their own. Management has a cease trade order from the OSC until the resolve their late financial reporting. Akumin brought a problem forward related to some accounting it identified as of the purchase.
Hope that all gets reslovled quickly (November).
Looks like one huge partnership brewing and if Akumin don't own or pay for the TULSA systems upfront ... I can see Akumin being interested in rolling out the systems. Afterall, Akumin need to pay for the blockbuster acquisition and maybe Profound is a good vehicle to do so.
Thoughts ?